Quimi Daphne has filed 17 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 44000 shares of Century Therapeutics, Inc. ($IPSC) on June 12, 2025.
Activity breakdown: 3 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Century Therapeutics, Inc. | $IPSC | Quimi Daphne | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 5, 2025 | Amylyx Pharmaceuticals, Inc. | $AMLX | Quimi Daphne | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 88,602,468 | 9999.99% | 0.03% |
| Sept. 12, 2024 | Century Therapeutics, Inc. | $IPSC | Quimi Daphne | Director | P | Common Stock | 5000 | $1.53 | 5,000.0000 | 82,092,167 | 9999.99% | 0.01% |
| June 20, 2024 | Century Therapeutics, Inc. | $IPSC | Quimi Daphne | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 6, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | Quimi Daphne | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | Quimi Daphne | Not found | P | Common Stock | 2750 | $1.89 | 2,750.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Amylyx Pharmaceuticals, Inc. | $AMLX | Quimi Daphne | Not found | P | Common Stock | 2250 | $1.89 | 5,000.0000 | 0 | 81.82% | 0.00% |
| June 8, 2023 | Amylyx Pharmaceuticals, Inc. | $AMLX | Quimi Daphne | Director | A | Stock Option (right to buy) | 16985 | $0.00 | 16,985.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | S | Common Stock | 5000 | $12.49 | 405,455.0000 | 289,057,198 | 1.22% | 0.00% |
| Jan. 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | S | Common Stock | 6923 | $13.00 | 398,532.0000 | 289,057,198 | 1.71% | 0.00% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | A | Common Stock | 58824 | $0.00 | 440,020.0000 | 289,057,198 | 15.43% | 0.02% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | F | Common Stock | 29565 | $12.02 | 410,455.0000 | 289,057,198 | 6.72% | 0.01% |
| Jan. 4, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | F | Common Stock | 3884 | $12.03 | 381,196.0000 | 289,057,198 | 1.01% | 0.00% |
| Jan. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | F | Common Stock | 15165 | $12.21 | 320,147.0000 | 289,057,198 | 4.52% | 0.01% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | A | Common Stock | 73508 | $0.00 | 393,655.0000 | 289,057,198 | 22.96% | 0.03% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | F | Common Stock | 8575 | $11.93 | 385,080.0000 | 289,057,198 | 2.18% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Quimi Daphne | Chief Financial Officer | A | Stock Options (right to buy) | 130480 | $0.00 | 130,480.0000 | 289,057,198 | 9999.99% | 0.05% |